Granahan Investment Management’s Harvard Bioscience HBIO Stock Holding History

Granahan Investment Management’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$666K	Sell	1,501,508 -26,386	-2%	-$11.7K	0.03%	147
2025 Q1	$865K	Sell	1,527,894 -89,284	-6%	-$50.5K	0.04%	144
2024 Q4	$3.41M	Sell	1,617,178 -248,251	-13%	-$524K	0.14%	131
2024 Q3	$5.02M	Sell	1,865,429 -59,969	-3%	-$161K	0.2%	129
2024 Q2	$5.49M	Buy	1,925,398 +61,648	+3%	+$176K	0.22%	120
2024 Q1	$7.9M	Buy	1,863,750 +20,266	+1%	+$85.9K	0.28%	100
2023 Q4	$9.86M	Buy	1,843,484 +107,912	+6%	+$577K	0.33%	90
2023 Q3	$7.46M	Buy	1,735,572 +296,122	+21%	+$1.27M	0.27%	104
2023 Q2	$7.9M	Buy	1,439,450 +9,299	+0.7%	+$51.1K	0.24%	104
2023 Q1	$6.01M	Sell	1,430,151 -32,306	-2%	-$136K	0.18%	114
2022 Q4	$4.05M	Sell	1,462,457 -30,812	-2%	-$85.3K	0.12%	142
2022 Q3	$3.82M	Sell	1,493,269 -39,424	-3%	-$101K	0.12%	141
2022 Q2	$5.52M	Buy	1,532,693 +75,944	+5%	+$273K	0.19%	113
2022 Q1	$9.05M	Sell	1,456,749 -201,074	-12%	-$1.25M	0.22%	99
2021 Q4	$11.7M	Buy	1,657,823 +78,168	+5%	+$551K	0.24%	105
2021 Q3	$11M	Buy	1,579,655 +40,095	+3%	+$280K	0.21%	107
2021 Q2	$12.8M	Buy	1,539,560 +20,237	+1%	+$169K	0.24%	96
2021 Q1	$8.3M	Sell	1,519,323 -4,029	-0.3%	-$22K	0.18%	105
2020 Q4	$6.54M	Sell	1,523,352 -233,824	-13%	-$1M	0.15%	116
2020 Q3	$5.29M	Buy	1,757,176 +24,033	+1%	+$72.3K	0.18%	102
2020 Q2	$5.37M	Sell	1,733,143 -113,005	-6%	-$350K	0.19%	104
2020 Q1	$4.08M	Sell	1,846,148 -38,685	-2%	-$85.5K	0.22%	94
2019 Q4	$5.75M	Buy	1,884,833 +112,869	+6%	+$344K	0.26%	86
2019 Q3	$5.45M	Buy	1,771,964 +848,191	+92%	+$2.61M	0.3%	80
2019 Q2	$1.85M	Sell	923,773 -62,928	-6%	-$126K	0.09%	146
2019 Q1	$4.25M	Sell	986,701 -104,982	-10%	-$453K	0.23%	108
2018 Q4	$3.47M	Sell	1,091,683 -22,807	-2%	-$72.5K	0.25%	99
2018 Q3	$5.85M	Buy	1,114,490 +39,127	+4%	+$205K	0.32%	90
2018 Q2	$5.75M	Buy	1,075,363 +113,716	+12%	+$608K	0.35%	91
2018 Q1	$4.81M	Buy	961,647 +25,930	+3%	+$130K	0.35%	94
2017 Q4	$3.09M	Buy	935,717 +398,250	+74%	+$1.31M	0.24%	120
2017 Q3	$2.02M	Buy	537,467 +240,055	+81%	+$900K	0.17%	137
2017 Q2	$758K	Sell	297,412 -718,316	-71%	-$1.83M	0.07%	159
2017 Q1	$2.64M	Sell	1,015,728 -522,087	-34%	-$1.36M	0.27%	111
2016 Q4	$4.69M	Buy	1,537,815 +216,700	+16%	+$661K	0.16%	151
2016 Q3	$3.59M	Buy	1,321,115 +34,390	+3%	+$93.5K	0.12%	165
2016 Q2	$3.68M	Sell	1,286,725 -55,070	-4%	-$157K	0.13%	163
2016 Q1	$4.05M	Sell	1,341,795 -71,420	-5%	-$216K	0.15%	169
2015 Q4	$4.9M	Sell	1,413,215 -289,831	-17%	-$1.01M	0.17%	167
2015 Q3	$6.44M	Sell	1,703,046 -48,900	-3%	-$185K	0.2%	159
2015 Q2	$9.99M	Buy	1,751,946 +125,310	+8%	+$714K	0.28%	127
2015 Q1	$9.47M	Sell	1,626,636 -15,640	-1%	-$91K	0.27%	134
2014 Q4	$9.31M	Sell	1,642,276 -2,314	-0.1%	-$13.1K	0.27%	122
2014 Q3	$6.73M	Sell	1,644,590 -63,626	-4%	-$260K	0.21%	146
2014 Q2	$7.77M	Sell	1,708,216 -47,700	-3%	-$217K	0.23%	143
2014 Q1	$8.32M	Buy	1,755,916 +31,956	+2%	+$151K	0.22%	148
2013 Q4	$8.1M	Buy	1,723,960 +392,660	+29%	+$1.85M	0.21%	149
2013 Q3	$5.31M	Buy	1,331,300 +38,278	+3%	+$153K	0.14%	168
2013 Q2	$4.61M	Buy	+1,293,022	New	+$4.61M	0.13%	173